Logo Logo
Help
Contact
Switch Language to German

Elger, T.; Decker, T.; Fehm, T.; Fuxius, S.; Harbeck, N.; Juhasz-Böss, I.; Möbus, V.; Thomssen, C.; Seehase, M.; Schollenberger, L.; Ruckes, C. and Schmidt, M. (2017): VinoMetro: Phase II study of metronomic daily oral vinorelbine as first-line chemotherapy in advanced/metastatic hormone receptor positive (HR plus )/human epidermal growth factor receptor 2 negative (HER2-) breast cancer resistant to endocrine therapy. In: Annals of Oncology, Vol. 28

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item